Selective MAO-B inhibitor that raises dopaminergic tone at lower doses and is used clinically in Parkinson's disease and select mood protocols.
Interactions
Significant serotonergic and sympathomimetic interaction burden
Contraindications
Do not combine casually with SSRIs or stimulants
Key Papers
Neurology and psychiatry literature on selegiline
Disclaimer: This information is for educational purposes only and is not medical advice. BioAccelera Labs does not diagnose, treat, or prescribe. Consult a licensed healthcare provider before using any compound.
Should Selegiline Be in Your Stack?
Take the free assessment and get personalized recommendations based on your biology and goals.